ATS
BSX icon

Ashton Thomas Securities’s Boston Scientific BSX Stock Holding History

Ashton Thomas Securities’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,441
Closed -$996K – 450
2025
Q4 		$996K Sell
10,441
-331
-3% -$32.5K 0.19% 106
2025
Q3 		$1.05M Buy
10,772
+273
+3% +$28.3K 0.15% 145
2025
Q2 		$1.13M Sell
10,499
-165
-2% -$16.7K 0.27% 96
2025
Q1 		$1.08M Buy
10,664
+348
+3% +$35K 0.3% 86
2024
Q4 		$921K Buy
10,316
+348
+3% +$30.6K 0.25% 96
2024
Q3 		$835K Buy
9,968
+129
+1% +$10.2K 0.16% 131
2024
Q2 		$753K Buy
+9,839
New +$720K 0.18% 129

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ashton Thomas Securities's BSX Position: Q1 2026 in Review

Ashton Thomas Securities sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 10,441 shares — an estimated $996K sold.

Ashton Thomas Securities first reported a position in BSX in Q2 2024 and held it in 7 quarters. The position peaked at $1.13M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Ashton Thomas Securities reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Ashton Thomas Securities sold 10,441 Boston Scientific shares in Q1 2026, an estimated $996K.
  • Ashton Thomas Securities first reported a position in Boston Scientific in Q2 2024 and held it in 7 quarters.
  • Ashton Thomas Securities's Boston Scientific position peaked at $1.13M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Ashton Thomas Securities's 13F filing for Q1 2026, filed 18 May 2026.